Article in Molecular psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
14 authors.
Marcel Tisch *Institute of Molecular Biology, Department of Genomics, Stem Cell Biology and Regenerative Medicine, Center for Molecular Biosciences, University of Innsbruck, Innsbruck, Austria.ORCID http://orcid.org/0000-0002-3907-6657
Stefanie M Geisler *Institute of Molecular Biology, Department of Genomics, Stem Cell Biology and Regenerative Medicine, Center for Molecular Biosciences, University of Innsbruck, Innsbruck, Austria.ORCID http://orcid.org/0000-0002-8898-0108
Elisa GabassiInstitute of Molecular Biology, Department of Genomics, Stem Cell Biology and Regenerative Medicine, Center for Molecular Biosciences, University of Innsbruck, Innsbruck, Austria.ORCID http://orcid.org/0000-0001-6053-503X
Quirin SchlemmerInstitute of Molecular Biology, Department of Genomics, Stem Cell Biology and Regenerative Medicine, Center for Molecular Biosciences, University of Innsbruck, Innsbruck, Austria.ORCID http://orcid.org/0009-0009-2492-9491
Miriam LechnerInstitute of Molecular Biology, Department of Genomics, Stem Cell Biology and Regenerative Medicine, Center for Molecular Biosciences, University of Innsbruck, Innsbruck, Austria.ORCID http://orcid.org/0000-0002-3761-3252
Julia-Anna UlzInstitute of Molecular Biology, Department of Genomics, Stem Cell Biology and Regenerative Medicine, Center for Molecular Biosciences, University of Innsbruck, Innsbruck, Austria.
Marta Suarez-CuberoInstitute of Molecular Biology, Department of Genomics, Stem Cell Biology and Regenerative Medicine, Center for Molecular Biosciences, University of Innsbruck, Innsbruck, Austria.ORCID http://orcid.org/0000-0002-4170-3947
Laura De GaetanoInstitute of Molecular Biology, Department of Genomics, Stem Cell Biology and Regenerative Medicine, Center for Molecular Biosciences, University of Innsbruck, Innsbruck, Austria.
Angeliki SpathopoulouInstitute of Molecular Biology, Department of Genomics, Stem Cell Biology and Regenerative Medicine, Center for Molecular Biosciences, University of Innsbruck, Innsbruck, Austria.ORCID http://orcid.org/0000-0001-9239-6222
Jörg StriessnigInstitute of Pharmacy, Department of Pharmacology and Toxicology, Center for Molecular Biosciences, University of Innsbruck, Innsbruck, Austria.
Nadine J OrtnerInstitute of Pharmacy, Department of Pharmacology and Toxicology, Center for Molecular Biosciences, University of Innsbruck, Innsbruck, Austria.
Katharina GüntherInstitute of Molecular Biology, Department of Genomics, Stem Cell Biology and Regenerative Medicine, Center for Molecular Biosciences, University of Innsbruck, Innsbruck, Austria.
Petronel TulucInstitute of Pharmacy, Department of Pharmacology and Toxicology, Center for Molecular Biosciences, University of Innsbruck, Innsbruck, Austria.ORCID http://orcid.org/0000-0003-3660-6138
Frank EdenhoferInstitute of Molecular Biology, Department of Genomics, Stem Cell Biology and Regenerative Medicine, Center for Molecular Biosciences, University of Innsbruck, Innsbruck, Austria. Frank.Edenhofer@uibk.ac.at.ORCID http://orcid.org/0000-0002-6489-714X
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
Voltage-gated calcium channels (VGCCs) are essential for neuronal excitability and synapse transmission as well as gene transcription regulation controlling cellular differentiation and survival. Recently, genetic variants in the CACNA1D gene, which encodes the α
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Aberrant calcium signaling and neuronal activity in the L271H CACNA1D (Cav1.3) iPSC model of neurodevelopmental disease. · full record | Socratic